Litcius/Paper detail

Patient-Reported and Toxicity Results from the FABREC Study: A Multicenter Randomized Trial of Hypofractionated vs. Conventionally-Fractionated Postmastectomy Radiation Therapy after Implant-Based Reconstruction

Julia S. Wong, Hajime Uno, Angela C. Tramontano, Chiara Pellegrini, Jennifer R. Bellon, Matthew D. Cheney, Patricia H. Hardenbergh, Alice Y. Ho, Kathleen C. Horst, J.N. Kim, K.L. Leonard, Meena S. Moran, C.C. Park, A. Recht, R. Shiloh, Alphonse G. Taghian, Laura Warren, Jean L. Wright, Y Chun, Rinaa S. Punglia

2023International Journal of Radiation Oncology*Biology*Physics23 citationsDOI

Topics & Concepts

MedicineMastectomyClinical endpointBreast cancerRandomized controlled trialRadiation therapyImplantQuality of life (healthcare)Dose fractionationBreast reconstructionSurgeryNuclear medicineCancerInternal medicineNursingCancer survivorship and careBreast Implant and ReconstructionBreast Cancer Treatment Studies
Patient-Reported and Toxicity Results from the FABREC Study: A Multicenter Randomized Trial of Hypofractionated vs. Conventionally-Fractionated Postmastectomy Radiation Therapy after Implant-Based Reconstruction | Litcius